189 related articles for article (PubMed ID: 33457238)
1. Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma.
Xiao Q; Yi X; Guan X; Yin H; Wang C; Zhang L; Pang Y; Li M; Gong G; Chen D; Liu L
Transl Androl Urol; 2020 Dec; 9(6):2665-2674. PubMed ID: 33457238
[TBL] [Abstract][Full Text] [Related]
2. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
[TBL] [Abstract][Full Text] [Related]
3. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
4. Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma.
Galtung KF; Lauritzen PM; Baco E; Berg RE; Naas AM; Rud E
Anticancer Res; 2022 Jun; 42(6):2967-2975. PubMed ID: 35641263
[TBL] [Abstract][Full Text] [Related]
5. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
6. WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
Browning L; Colling R; Verrill C
Diagn Pathol; 2021 Aug; 16(1):75. PubMed ID: 34419085
[TBL] [Abstract][Full Text] [Related]
7. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
[TBL] [Abstract][Full Text] [Related]
9. [The WHO/ISUP grading system for renal carcinoma].
Moch H
Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
[TBL] [Abstract][Full Text] [Related]
10. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
Murase Y; Iwata H; Takahara T; Tsuzuki T
Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
[TBL] [Abstract][Full Text] [Related]
11. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.
Liu N; Gan W; Qu F; Wang Z; Zhuang W; Agizamhan S; Xu L; Yin J; Guo H; Li D
Am J Pathol; 2018 Apr; 188(4):929-936. PubMed ID: 29571325
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
Offermann A; Hohensteiner S; Kuempers C; Ribbat-Idel J; Schneider F; Becker F; Hupe MC; Duensing S; Merseburger AS; Kirfel J; Reischl M; Lubczyk V; Kuefer R; Perner S
Front Med (Lausanne); 2017; 4():157. PubMed ID: 29034236
[TBL] [Abstract][Full Text] [Related]
13. Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT.
Zhang X; Zhang G; Xu L; Bai X; Zhang J; Chen L; Lu X; Yu S; Jin Z; Sun H
Acad Radiol; 2023 Oct; 30(10):2321-2328. PubMed ID: 36543688
[TBL] [Abstract][Full Text] [Related]
14. World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading in fine-needle aspiration biopsies of renal masses.
Perrino CM; Cramer HM; Chen S; Idrees MT; Wu HH
Diagn Cytopathol; 2018 Nov; 46(11):895-900. PubMed ID: 30488673
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
16. Collateral vessels on preoperative enhanced computed tomography for predicting pathological grade of clear cell renal cell carcinoma: A retrospective study.
Shi Y; Ni L; Pei J; Zhan H; Li H; Zhang D; Wang L
Eur J Radiol; 2024 Jan; 170():111240. PubMed ID: 38043383
[TBL] [Abstract][Full Text] [Related]
17. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
[TBL] [Abstract][Full Text] [Related]
18. An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma.
Yin F; Zhang H; Qi A; Zhu Z; Yang L; Wen G; Xie W
Front Oncol; 2022; 12():979613. PubMed ID: 36387121
[TBL] [Abstract][Full Text] [Related]
19. Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study.
Choi J; Bang S; Suh J; Choi CI; Song W; Yuk HD; Lee CH; Kang M; Choo SH; Kim JK; Lee HH; Jo JK; Hwang EC; Jeong CW; Ko YH; Park JY; Song C; Seo SI; Chung J; Kwak C; Hong SH
Sci Rep; 2024 Feb; 14(1):4740. PubMed ID: 38413653
[TBL] [Abstract][Full Text] [Related]
20. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
